Sanofi introduces new multiple myeloma treatment to Egyptian market
A new treatment option for patients living with multiple myeloma has become available in Egypt following the launch of Sarclisa, marking a significant development in the management of one of the most common forms of blood cancer. The treatment is
Egypt among first nations to launch national strategy against antimicrobial resistance: Health Minister
Egypt’s Deputy Prime Minister and Minister of Health, Khaled Abdel Ghaffar, emphasized that antimicrobial resistance (AMR) is not merely a medical issue but a global crisis requiring a coordinated, multi-sectoral response. Speaking at the Second National Conference on Infection Control
Sanofi’s Gaucher initiative marks 25 years of rare disease care in Egypt
Sanofi, through its philanthropic organisation Foundation S, is celebrating the 25th anniversary of The Gaucher Initiative, a cornerstone of its Rare Humanitarian Program, in partnership with Project HOPE. The program, which began in 1999, has provided life-saving treatment to patients



